Lv4
544 积分 2022-03-28 加入
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
20分钟前
待确认
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial
3天前
已完结
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy
3天前
已完结
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC)
3天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
12天前
已完结
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
13天前
已完结
Clinical application of base editing for treating β-thalassaemia
13天前
已完结
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
14天前
已完结
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
14天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
14天前
已完结
皖公网安备34019202002308
